3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
2
Phase 2
1
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Conditions
Multiple Myeloma
338
Neoplasms, Plasma Cell
56
Precursor Cell Lymphoblastic Leukemia-Lymphoma
54
Recurrence
50
Lymphoma
48
Leukemia
39
Neoplasms
27
Lymphoma, Mantle-Cell
27
Burkitt Lymphoma
26
Lymphoma, Large B-Cell, Diffuse
23
Immunoglobulin Light-chain Amyloidosis
23
Lymphoma, Non-Hodgkin
22
Waldenstrom Macroglobulinemia
21
Lymphoma, Follicular
17
Leukemia, Lymphocytic, Chronic, B-Cell
16
Hodgkin Disease
14
Nausea
12
Lymphoma, Extranodal NK-T-Cell
12
Lymphoma, B-Cell, Marginal Zone
12
Vomiting
11
Smoldering Multiple Myeloma
11
Prostatic Neoplasms
11
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
11
Breast Neoplasms
11
Renal Insufficiency
10
Neoplasm Metastasis
9
Lymphoma, Large-Cell, Immunoblastic
9
Carcinoma, Non-Small-Cell Lung
9
Lung Neoplasms
8
Leukemia, Biphenotypic, Acute
7
Interventions
Pemetrexed
10
Cisplatin
9
Gemcitabine
8
Nivolumab
5
Ipilimumab
4
Carboplatin
4
niraparib
3
durvalumab
3
Vinorelbine
3
Bevacizumab
3
tremelimumab
2
pembrolizumab
2
olaparib
2
anetumab ravtansine
2
Radiotherapy, Intensity-Modulated
2
Oxaliplatin
2
Imatinib Mesylate
2
Hyperthermic Intraperitoneal Chemotherapy
2
Fluorodeoxyglucose F18
2
Cytoreduction Surgical Procedures
2
vandetanib
1
tislelizumab
1
tazemetostat
1
spartalizumab
1
sargramostim
1
ribociclib
1
fludarabine phosphate
1
fludarabine
1
dostarlimab
1
defactinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Mesothelioma
×
Dexamethasone
×
Clear all
NCT01569919
2013-03-12
SKOPOS
Wales Cancer Trials Unit
Phase 2
Unknown
26 enrolled